Enhance your practice with CME and tools that focus on the management of neurological conditions.
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
Uncovering TK2d: How to Navigate Diagnostic Challenges
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
Immunologic Phenotyping: The Future of Personalized MG Care
Navigating Emerging Treatment Options in MG
Qihua Fan, MD
Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
The Next Frontier: Addressing Persistent Cognitive Impairment in Bipolar Disorder
Navigating the Limitations of Current BD Therapies
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Discharge Planning After Myasthenic Crisis
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
New Therapies, New Strategy: Rethinking MG Inpatient Care
More Than a Myopathy: The Lived Experience of TK2d
Outcome Measures Capture Progression in Late-Onset TK2d
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.